The forecast for mortality due to trachea, bronchus, or lung malignant neoplasms among men in Canada shows a declining trend from 53.2 deaths per 100,000 in 2024 to 51.1 in 2028. Considering the last available actual data in 2023 was 53.9 deaths per 100,000, there is a continuous annual decrease. The year-on-year decline is steady, marking reductions of 0.5 to 0.6 percentage points annually. The compound annual growth rate (CAGR), which provides an average yearly change over these five forecast years, indicates a consistent and modest decline, reflecting improvements in healthcare interventions and smoking cessation campaigns.
Looking to the future, trends to watch for include advancements in early detection and treatment technologies, expanded health policies focused on prevention, and broader public health initiatives aimed at reducing smoking rates. These factors could contribute further to the downward trend in mortality rates.
